dMY Squared Technology Group Inc

NYSE MKT:DMYY USA Shell Companies
Market Cap
$36.33 Million
Market Cap Rank
#23191 Global
#8133 in USA
Share Price
$13.25
Change (1 day)
+10.42%
52-Week Range
$11.07 - $15.00
All Time High
$15.00
About

dMY Squared Technology Group, Inc. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the professional service industry that offers accounting, legal, financial, advisory, and other services. The company was incorporated in 2022 and is based i… Read more

dMY Squared Technology Group Inc (DMYY) - Net Assets

Latest net assets as of September 2025: $6.36 Million USD

Based on the latest financial reports, dMY Squared Technology Group Inc (DMYY) has net assets worth $6.36 Million USD as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($27.18 Million) and total liabilities ($20.83 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $6.36 Million
% of Total Assets 23.39%
Annual Growth Rate -43.86%
5-Year Change N/A
10-Year Change N/A
Growth Volatility 36.78

dMY Squared Technology Group Inc - Net Assets Trend (2022–2024)

This chart illustrates how dMY Squared Technology Group Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for dMY Squared Technology Group Inc (2022–2024)

The table below shows the annual net assets of dMY Squared Technology Group Inc from 2022 to 2024.

Year Net Assets Change
2024-12-31 $18.64 Million -69.68%
2023-12-31 $61.48 Million +3.88%
2022-12-31 $59.18 Million --

Equity Component Analysis

This analysis shows how different components contribute to dMY Squared Technology Group Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 166882400.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock $25.49 Million 136.73%
Total Equity $18.64 Million 100.00%

dMY Squared Technology Group Inc Competitors by Market Cap

The table below lists competitors of dMY Squared Technology Group Inc ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in dMY Squared Technology Group Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 61,480,950 to 18,641,108, a change of -42,839,842 (-69.7%).
  • Net loss of 819,410 reduced equity.
  • Share repurchases of 42,020,432 reduced equity.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income $-819.41K -4.4%
Share Repurchases $42.02 Million -225.42%
Total Change $- -69.68%

Book Value vs Market Value Analysis

This analysis compares dMY Squared Technology Group Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.69x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2022-12-31 $7.49 $13.25 x
2023-12-31 $7.78 $13.25 x
2024-12-31 $7.86 $13.25 x

Capital Efficiency Dashboard

This dashboard shows how efficiently dMY Squared Technology Group Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -4.40%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 0.00%
  • • Asset Turnover: 0.00x
  • • Equity Multiplier: 1.40x
  • Recent ROE (-4.40%) is below the historical average (-1.56%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2022 -4.04% 0.00% 0.00x 1.11x $-8.31 Million
2023 3.74% 0.00% 0.00x 1.10x $-3.85 Million
2024 -4.40% 0.00% 0.00x 1.40x $-2.68 Million

Industry Comparison

This section compares dMY Squared Technology Group Inc's net assets metrics with peer companies in the Shell Companies industry.

Industry Context

  • Industry: Shell Companies
  • Average net assets among peers: $36,677,338
  • Average return on equity (ROE) among peers: -64.57%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
dMY Squared Technology Group Inc (DMYY) $6.36 Million -4.04% 3.28x $32.88 Million
Artius II Acquisition Inc. Class A Ordinary Shares (AACB) $-60.27K 0.00% 0.00x $198.37 Million
Artius II Acquisition Inc. Units (AACBU) $-60.27K 0.00% 0.00x $205.28 Million
Ares Acquisition Corporation II (AACT-UN) $931.34 Million 0.00% 0.08x $399.77 Million
AA Mission Acquisition Corp. (AAM-UN) $-559.90 Million 0.00% 0.00x $349.76 Million
Global Acquisitions Corporation (AASP) $3.80 Million -5.26% 0.34x $15.42 Million
ABV Consulting Inc (ABVN) $8.75K -623.31% 2.50x $461.96K
Atlantic Coastal Acquisition Corp II (ACAB) $-8.52 Million 0.00% 0.00x $2.44 Million
Annabidiol Corp (ACBD) $-501.57K 0.00% 0.00x $13.62K
ACRO Biomedical Co Ltd (ACBM) $685.87K -17.12% 0.46x $30.04K
Huaizhong Health Group Inc (ADAD) $-19.47K 0.00% 0.00x $3.15K